Appearance of ANCA – associated vasculitis under Tumor necrosis factor-alpha inhibitors treatment

BACKGROUND: Tumor necrosis factor-alpha inhibitors treatment is accosiated with several side effects. The most common are injection side reactions, headache, nausea and infections. The more rare are development of systemic autoimmune diseases. CASE REPORT: We describe two patients, who developed ANC...

Descripción completa

Detalles Bibliográficos
Autores principales: Reitblat, Tatiana, Reitblat, Olga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619044/
https://www.ncbi.nlm.nih.gov/pubmed/23569570
http://dx.doi.org/10.12659/AJCR.883841
_version_ 1782265453886832640
author Reitblat, Tatiana
Reitblat, Olga
author_facet Reitblat, Tatiana
Reitblat, Olga
author_sort Reitblat, Tatiana
collection PubMed
description BACKGROUND: Tumor necrosis factor-alpha inhibitors treatment is accosiated with several side effects. The most common are injection side reactions, headache, nausea and infections. The more rare are development of systemic autoimmune diseases. CASE REPORT: We describe two patients, who developed ANCA associated vasculitis during Tumor necrosis factor alpha inhibitors treatment. The diagnosis was confirmed by appropriate tissue picture, CT scan and laboratory findings. CONCLUSIONS: Our case series are unique, because vasculitis appeared after many years of the treatment and during complete patient’s remission of there main illness.
format Online
Article
Text
id pubmed-3619044
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-36190442013-04-08 Appearance of ANCA – associated vasculitis under Tumor necrosis factor-alpha inhibitors treatment Reitblat, Tatiana Reitblat, Olga Am J Case Rep Case Report BACKGROUND: Tumor necrosis factor-alpha inhibitors treatment is accosiated with several side effects. The most common are injection side reactions, headache, nausea and infections. The more rare are development of systemic autoimmune diseases. CASE REPORT: We describe two patients, who developed ANCA associated vasculitis during Tumor necrosis factor alpha inhibitors treatment. The diagnosis was confirmed by appropriate tissue picture, CT scan and laboratory findings. CONCLUSIONS: Our case series are unique, because vasculitis appeared after many years of the treatment and during complete patient’s remission of there main illness. International Scientific Literature, Inc. 2013-03-20 /pmc/articles/PMC3619044/ /pubmed/23569570 http://dx.doi.org/10.12659/AJCR.883841 Text en © Am J Case Rep, 2013 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License
spellingShingle Case Report
Reitblat, Tatiana
Reitblat, Olga
Appearance of ANCA – associated vasculitis under Tumor necrosis factor-alpha inhibitors treatment
title Appearance of ANCA – associated vasculitis under Tumor necrosis factor-alpha inhibitors treatment
title_full Appearance of ANCA – associated vasculitis under Tumor necrosis factor-alpha inhibitors treatment
title_fullStr Appearance of ANCA – associated vasculitis under Tumor necrosis factor-alpha inhibitors treatment
title_full_unstemmed Appearance of ANCA – associated vasculitis under Tumor necrosis factor-alpha inhibitors treatment
title_short Appearance of ANCA – associated vasculitis under Tumor necrosis factor-alpha inhibitors treatment
title_sort appearance of anca – associated vasculitis under tumor necrosis factor-alpha inhibitors treatment
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619044/
https://www.ncbi.nlm.nih.gov/pubmed/23569570
http://dx.doi.org/10.12659/AJCR.883841
work_keys_str_mv AT reitblattatiana appearanceofancaassociatedvasculitisundertumornecrosisfactoralphainhibitorstreatment
AT reitblatolga appearanceofancaassociatedvasculitisundertumornecrosisfactoralphainhibitorstreatment

Ejemplares similares